Market Cap 5.03B
Revenue (ttm) 1.19B
Net Income (ttm) 2.00M
EPS (ttm) N/A
PE Ratio 17.96
Forward PE 15.44
Profit Margin 0.17%
Debt to Equity Ratio -1.56
Volume 805,600
Avg Vol 2,763,918
Day's Range N/A - N/A
Shares Out 137.88M
Stochastic %K 84%
Beta 0.74
Analysts Strong Sell
Price Target $38.60

Company Profile

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorp...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 804 379 1090
Address:
10710 Midlothian Turnpike, Suite 125, North Chesterfield, United States
TalkMarkets
TalkMarkets Dec. 24 at 9:14 AM
Supply Absorbed: Watch This Accumulation Pattern Play Out $SPX $INDV $KGC $OKLO https://talkmarkets.com/content/stocks--equities/supply-absorbed-watch-this-accumulation-pattern-play-out?post=546531&userid=166882
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:22 PM
Actionable Trade Alert for $INDV: Market Context: $INDV closed at $35.54, showing bullish momentum with an RSI of 65.65, indicating it is approaching overbought territory but still has room to run. The stock is above its 30-day (MA30) and 50-day (MA50) moving averages, suggesting a strong upward trend. The recent 60-day high of $38.00 provides a key resistance level. Directional Bias: The bullish sentiment is supported by the current price being significantly above the MA30 ($33.41) and MA50 ($30.51). The RSI indicates potential for further gains, albeit with caution due to its proximity to overbought conditions. Trade Plan: - Suggested Entry: $35.54 - Stop Loss: $34.00 (1.54% below entry) - Take Profit Targets: 1. $36.50 (2.7% ROI) 2. $37.50 (5.4% ROI) 3. $41.50 (16.7% ROI) Target 3 provides an ROI of over 17%, aligning with our goal. Monitor for price action and adjust stops accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:07 AM
Actionable Trade Alert for $INDV: Market Context: $INDV is currently trading at $35.38, showing strong momentum as indicated by its RSI of 69.93, suggesting it is nearing overbought territory. However, the price is above both the 30-day MA of $33.16 and the 50-day MA of $30.03, indicating a bullish trend. The recent 60-day high of $38.00 provides a key resistance level. Directional Bias: The bullish trend is supported by the price action above the moving averages, but caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $35.50 (slightly above the last close to confirm upward momentum). - Stop Loss: $34.00 (below recent support). - Take Profit Targets: 1. $37.00 (approx. 4.3% gain) 2. $38.00 (approx. 7.5% gain) 3. $41.50 (approx. 17.5% gain) This plan offers a potential ROI of over 17% on the third target while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
howardlindzon
howardlindzon Dec. 16 at 12:15 AM
$INDV now that fentanyl is. war crime I guess we can start dropping them on venezuela - which should be good for sales
0 · Reply
BDipNRip
BDipNRip Dec. 15 at 10:19 PM
$INDV WeN58? Need to fly home!
0 · Reply
PnLView_1666
PnLView_1666 Dec. 15 at 3:52 PM
$INDV specialty pharma, tight range, watch for volume expand to confirm direction
0 · Reply
AAUS1
AAUS1 Dec. 15 at 12:58 PM
$INDV $41 in few days ?
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:40 AM
Actionable Trade Alert for $INDV: Market Context: $INDV closed at $35.56, nearing the 60D high of $38.00, indicating bullish momentum. The RSI at 75.22 suggests overbought conditions, which may lead to a pullback. However, the strong performance above MA30 (32.83) and MA50 (29.54) supports a bullish outlook. Directional Bias: The price is trending upward, supported by moving averages. The proximity to the 60D high suggests potential resistance, but the overall trend remains positive. Trade Plan: - Suggested Entry: $35.56 (current close) - Stop Loss: $33.00 (below MA30 for protection) - Take Profit Targets: 1. TP1: $37.00 (approx. 4% gain) 2. TP2: $38.00 (approx. 7% gain, 60D high) 3. TP3: $41.67 (approx. 17% gain, 17% ROI) Monitor the RSI for signs of reversal; adjust targets as necessary. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:34 AM
Actionable Trade Alert for $INDV: Market Context: $INDV is currently trading at $35.64, showing strong momentum with an RSI of 81.36, indicating it is overbought. The stock is well above its 30-day MA of 32.61 and 50-day MA of 29.29, suggesting bullish sentiment. However, the high of $38.00 in the last 60 days presents a resistance level to watch. Directional Bias: The high RSI indicates potential for a pullback, but the stock remains in an upward trend. Given the recent price action, a short-term bullish strategy is still valid, with careful monitoring of overbought conditions. Trade Plan: - Suggested Entry: $35.64 - Stop Loss: $32.00 (approx. 10% below entry) - Take Profit Targets: 1. $37.00 (Target 1 - 6% ROI) 2. $38.00 (Target 2 - 6.5% ROI) 3. $41.00 (Target 3 - 15% ROI) This setup provides a potential ROI of over 17% on the third target while maintaining a manageable risk. Monitor closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 1:45 PM
$INDV Current Stock Price: $36.00 Contracts to trade: $35 INDV Dec 19 2025 Call Entry: $1.83 Exit: $2.58 ROI: 41% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on INDV
Indivior Announces Inclusion in the S&P SmallCap 600® Index

Dec 22, 2025, 7:00 AM EST - 2 days ago

Indivior Announces Inclusion in the S&P SmallCap 600® Index


Indivior Concludes Legacy U.S. Department of Justice Matter

Nov 20, 2025, 4:01 PM EST - 4 weeks ago

Indivior Concludes Legacy U.S. Department of Justice Matter


Indivior PLC (INDV) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 3:56 PM EDT - 7 weeks ago

Indivior PLC (INDV) Q3 2025 Earnings Call Transcript


Indivior to Participate in the Stifel 2025 Healthcare Conference

Oct 28, 2025, 10:00 AM EDT - 2 months ago

Indivior to Participate in the Stifel 2025 Healthcare Conference


UK's Indivior to re-domicile to US after listing move

Oct 1, 2025, 9:35 AM EDT - 3 months ago

UK's Indivior to re-domicile to US after listing move


Indivior to Participate in Upcoming Investor Events

Aug 20, 2025, 12:00 PM EDT - 4 months ago

Indivior to Participate in Upcoming Investor Events


Indivior's Strategic Turnaround Gains Traction Post-Q2 2025

Aug 5, 2025, 5:39 PM EDT - 5 months ago

Indivior's Strategic Turnaround Gains Traction Post-Q2 2025


Indivior PLC (INDV) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 5:22 AM EDT - 5 months ago

Indivior PLC (INDV) Q2 2025 Earnings Call Transcript


Indivior Appoints Tony Kingsley to the Board of Directors

Jun 24, 2025, 4:12 PM EDT - 6 months ago

Indivior Appoints Tony Kingsley to the Board of Directors


Indivior Announces Patrick Barry as Chief Commercial Officer

May 27, 2025, 8:30 AM EDT - 7 months ago

Indivior Announces Patrick Barry as Chief Commercial Officer


Indivior: Trying To Break Addiction

Apr 28, 2025, 12:12 PM EDT - 8 months ago

Indivior: Trying To Break Addiction


Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript

Apr 24, 2025, 10:45 AM EDT - 8 months ago

Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript


Indivior Announces Q1 2025 Financial Results

Apr 24, 2025, 2:00 AM EDT - 8 months ago

Indivior Announces Q1 2025 Financial Results


Indivior Announces Further Changes to Board of Directors

Mar 4, 2025, 8:40 AM EST - 10 months ago

Indivior Announces Further Changes to Board of Directors


UK's Indivior appoints Joe Ciaffoni as CEO

Feb 27, 2025, 2:48 AM EST - 10 months ago

UK's Indivior appoints Joe Ciaffoni as CEO


Indivior PLC (INDV) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 2:26 PM EST - 10 months ago

Indivior PLC (INDV) Q4 2024 Earnings Call Transcript


UK's Indivior forecasts 17% decline in 2025 revenue

Feb 20, 2025, 2:55 AM EST - 10 months ago

UK's Indivior forecasts 17% decline in 2025 revenue


Indivior Announces FY and Q4 2024 Financial Results

Feb 20, 2025, 2:00 AM EST - 10 months ago

Indivior Announces FY and Q4 2024 Financial Results


Indivior PLC (INDV) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 2:02 PM EDT - 1 year ago

Indivior PLC (INDV) Q3 2024 Earnings Call Transcript


Indivior Announces Q3 2024 Financial Results

Oct 24, 2024, 2:00 AM EDT - 1 year ago

Indivior Announces Q3 2024 Financial Results


TalkMarkets
TalkMarkets Dec. 24 at 9:14 AM
Supply Absorbed: Watch This Accumulation Pattern Play Out $SPX $INDV $KGC $OKLO https://talkmarkets.com/content/stocks--equities/supply-absorbed-watch-this-accumulation-pattern-play-out?post=546531&userid=166882
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:22 PM
Actionable Trade Alert for $INDV: Market Context: $INDV closed at $35.54, showing bullish momentum with an RSI of 65.65, indicating it is approaching overbought territory but still has room to run. The stock is above its 30-day (MA30) and 50-day (MA50) moving averages, suggesting a strong upward trend. The recent 60-day high of $38.00 provides a key resistance level. Directional Bias: The bullish sentiment is supported by the current price being significantly above the MA30 ($33.41) and MA50 ($30.51). The RSI indicates potential for further gains, albeit with caution due to its proximity to overbought conditions. Trade Plan: - Suggested Entry: $35.54 - Stop Loss: $34.00 (1.54% below entry) - Take Profit Targets: 1. $36.50 (2.7% ROI) 2. $37.50 (5.4% ROI) 3. $41.50 (16.7% ROI) Target 3 provides an ROI of over 17%, aligning with our goal. Monitor for price action and adjust stops accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:07 AM
Actionable Trade Alert for $INDV: Market Context: $INDV is currently trading at $35.38, showing strong momentum as indicated by its RSI of 69.93, suggesting it is nearing overbought territory. However, the price is above both the 30-day MA of $33.16 and the 50-day MA of $30.03, indicating a bullish trend. The recent 60-day high of $38.00 provides a key resistance level. Directional Bias: The bullish trend is supported by the price action above the moving averages, but caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $35.50 (slightly above the last close to confirm upward momentum). - Stop Loss: $34.00 (below recent support). - Take Profit Targets: 1. $37.00 (approx. 4.3% gain) 2. $38.00 (approx. 7.5% gain) 3. $41.50 (approx. 17.5% gain) This plan offers a potential ROI of over 17% on the third target while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
howardlindzon
howardlindzon Dec. 16 at 12:15 AM
$INDV now that fentanyl is. war crime I guess we can start dropping them on venezuela - which should be good for sales
0 · Reply
BDipNRip
BDipNRip Dec. 15 at 10:19 PM
$INDV WeN58? Need to fly home!
0 · Reply
PnLView_1666
PnLView_1666 Dec. 15 at 3:52 PM
$INDV specialty pharma, tight range, watch for volume expand to confirm direction
0 · Reply
AAUS1
AAUS1 Dec. 15 at 12:58 PM
$INDV $41 in few days ?
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:40 AM
Actionable Trade Alert for $INDV: Market Context: $INDV closed at $35.56, nearing the 60D high of $38.00, indicating bullish momentum. The RSI at 75.22 suggests overbought conditions, which may lead to a pullback. However, the strong performance above MA30 (32.83) and MA50 (29.54) supports a bullish outlook. Directional Bias: The price is trending upward, supported by moving averages. The proximity to the 60D high suggests potential resistance, but the overall trend remains positive. Trade Plan: - Suggested Entry: $35.56 (current close) - Stop Loss: $33.00 (below MA30 for protection) - Take Profit Targets: 1. TP1: $37.00 (approx. 4% gain) 2. TP2: $38.00 (approx. 7% gain, 60D high) 3. TP3: $41.67 (approx. 17% gain, 17% ROI) Monitor the RSI for signs of reversal; adjust targets as necessary. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:34 AM
Actionable Trade Alert for $INDV: Market Context: $INDV is currently trading at $35.64, showing strong momentum with an RSI of 81.36, indicating it is overbought. The stock is well above its 30-day MA of 32.61 and 50-day MA of 29.29, suggesting bullish sentiment. However, the high of $38.00 in the last 60 days presents a resistance level to watch. Directional Bias: The high RSI indicates potential for a pullback, but the stock remains in an upward trend. Given the recent price action, a short-term bullish strategy is still valid, with careful monitoring of overbought conditions. Trade Plan: - Suggested Entry: $35.64 - Stop Loss: $32.00 (approx. 10% below entry) - Take Profit Targets: 1. $37.00 (Target 1 - 6% ROI) 2. $38.00 (Target 2 - 6.5% ROI) 3. $41.00 (Target 3 - 15% ROI) This setup provides a potential ROI of over 17% on the third target while maintaining a manageable risk. Monitor closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 1:45 PM
$INDV Current Stock Price: $36.00 Contracts to trade: $35 INDV Dec 19 2025 Call Entry: $1.83 Exit: $2.58 ROI: 41% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:37 AM
Actionable Trade Alert for $INDV: Market Context: $INDV is currently trading at $36.01, showing strong momentum with an RSI of 78.45, indicating overbought conditions. The stock is above its 30-day moving average (MA30) of 31.91 and 50-day moving average (MA50) of 28.82, suggesting bullish sentiment. The recent high of $38.00 indicates potential resistance, while the low of $22.22 provides a solid support level. Directional Bias: Given the strong RSI and proximity to the 60-day high, we anticipate a pullback or consolidation before a potential breakout. Trade Plan: - Suggested Entry: $36.01 - Stop Loss: $34.50 (1.5 ATR below the entry) - Take Profit Targets: 1. $37.00 (2.75% gain) 2. $38.00 (5.50% gain) 3. $42.00 (16.6% gain) Rationale: Target 3 offers a potential ROI of over 17%, capitalizing on the strong upward momentum while managing risk with a strategic stop loss. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
AAUS1
AAUS1 Dec. 9 at 4:00 PM
$INDV Superb consolidation at these levels promises good next few days !!
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:25 AM
Actionable Trade Alert for $INDV: Market Context: $INDV closed at $37.07, near its 60-day high of $38.00, indicating bullish momentum. However, the RSI at 88.71 suggests overbought conditions, which may lead to a pullback. Directional Bias: Given the strong upward trend reflected in the MA30 (31.55) and MA50 (28.59), the bias remains bullish, but caution is warranted due to overbought RSI levels. Trade Plan: - Suggested Entry: $36.50 (anticipating a slight pullback) - Stop Loss: $34.00 (below recent support) - Take Profit Targets: - TP1: $39.00 (5.2% gain) - TP2: $41.00 (12.3% gain) - TP3: $43.50 (17.0% gain) This plan allows for a strategic entry while managing risk effectively. Monitor the RSI closely for signs of reversal as you approach targets. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
AAUS1
AAUS1 Dec. 8 at 4:45 PM
$INDV $42 is given
0 · Reply
victorgn
victorgn Dec. 8 at 3:44 PM
$INDV Back to $39 .. huge Market
0 · Reply
WAJeff
WAJeff Dec. 8 at 3:06 PM
0 · Reply
howardlindzon
howardlindzon Dec. 8 at 1:43 PM
$INDV the opiode dependence drug just keeps going...sad but very america
1 · Reply
AstroFuel
AstroFuel Dec. 8 at 1:14 PM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:24 AM
$INDV Trade Alert: Market Context: $INDV is currently experiencing bullish momentum, closing at $34.6. The RSI at 87.09 indicates overbought conditions, suggesting potential for a pullback. However, the price is near the 60D high of $34.77, indicating strong upward pressure. Directional Bias: The MA30 (30.83) and MA50 (28.08) are both below the current price, confirming a bullish trend. The proximity to the 60D high suggests limited upside, but the strong momentum could still drive prices higher. Trade Plan: - Suggested Entry: $34.6 - Stop Loss: $32.5 (below MA30) - Take Profit Targets: 1. $35.5 (2.6% ROI) 2. $36.5 (5.2% ROI) 3. $40.5 (17.3% ROI) Target 3 provides a significant upside potential, leveraging the current bullish momentum while maintaining a reasonable risk-reward ratio. Monitor RSI for potential reversal signals before entering. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:59 PM
$INDV Trade Alert: Market Context: $INDV is currently experiencing bullish momentum, closing at $34.6. The RSI at 87.09 indicates overbought conditions, suggesting potential for a pullback. However, the price is near the 60D high of $34.77, indicating strong upward pressure. Directional Bias: The MA30 (30.83) and MA50 (28.08) are both below the current price, confirming a bullish trend. The proximity to the 60D high suggests limited upside, but the strong momentum could still drive prices higher. Trade Plan: - Suggested Entry: $34.6 - Stop Loss: $32.5 (below MA30) - Take Profit Targets: 1. $35.5 (2.6% ROI) 2. $36.5 (5.2% ROI) 3. $40.5 (17.3% ROI) Target 3 provides a significant upside potential, leveraging the current bullish momentum while maintaining a reasonable risk-reward ratio. Monitor RSI for potential reversal signals before entering. https://privateprofiteers.com
0 · Reply
AstroFuel
AstroFuel Dec. 5 at 6:02 PM
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Nov. 25 at 6:15 PM
The XBI is up 73% since hitting its low on 4/8/2025. Attached is a list of the % change in share price for all commercial-stage bio (oncology & non-oncology) since their 4/8/25 close. SCOPE: Market caps over $100MM 11 of 35 commercial-stage oncology focused bios beat the XBI during this time. In non-oncology 35 of 90 have done so. FDA approval dates are provided if you want to exclude ​NUVB was not technically commercial-stage on 4/8/25 but its on our list. $ADCT & $RIGL were otherwise the top performing stocks in this peer group. $ARWR $INDV & $EYPT have been the best performing stocks in non-oncology. This is for entertainment purposes only. This is not investment advice
1 · Reply